Journal profile · Oncology
Japanese Journal of Clinical Oncology
ISSN 0368-2811 · eISSN 1465-3621 · Oxford University Press · JAPAN · Monthly · Founded 1971
Japanese Journal of Clinical Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.48; hybrid open access; APC about USD 3,604; median 60 days to acceptance (103 articles, last 24 months); community-reported acceptance: easy; 228 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Japanese Journal of Clinical Oncology is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations and Lung Cancer Diagnosis and Treatment, together about 18.7% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region. JJCO publishes various articles types including: ・Original Articles ・Case Reports ・Clinical Trial Notes ・Cancer Genetics Reports ・Epidemiology Notes ・Technical Notes ・Short Communications ・Letters to the Editors ・Solicited Reviews
Source: LetPub
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine7%
- Lung Cancer Treatments and MutationsMedicine6.5%
- Lung Cancer Diagnosis and TreatmentMedicine5.2%
- Head and Neck Cancer StudiesMedicine5.1%
- Lung Cancer Research StudiesMedicine4.8%
- Bladder and Urothelial Cancer TreatmentsMedicine4.6%
- Esophageal Cancer Research and TreatmentMedicine4.6%
- Multiple and Secondary Primary CancersMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.48LetPub ·
- CiteScore 2026-06
- 3.7LetPub ·
- SJR 2026-06
- 0.65LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 79LetPub ·
- h-index
- 116OpenAlex ·
- i10-index
- 3,254OpenAlex ·
- 2-year mean citedness
- 2.27OpenAlex ·
- Self-citation rate
- 8%LetPub ·
- Share of gold OA articles
- 24.95%LetPub ·
Volume
- Articles per year
- 179LetPub ·
Articles by year OpenAlex count · 7,158 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 164 | 41 | 42 |
| 2025 | 228 | 70 | 416 |
| 2024 | 196 | 124 | 879 |
| 2023 | 191 | 102 | 1,247 |
| 2022 | 207 | 88 | 1,635 |
| 2021 | 226 | 76 | 1,785 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
60 daysMedian, submission to acceptance · P25–P75 38 days – 91 days
- Acceptance to online
- median 20 days (58 articles)
- Submission to online
- median 81 days
- Sample
- 103 articles with submission and acceptance dates (482 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,604 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- JAPAN
- Language
- English
- Frequency
- Monthly
- Founded
- 1971
- ISSN
- 0368-2811
- Electronic ISSN
- 1465-3621
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Japanese Journal of Clinical Oncology
What CAS zone is Japanese Journal of Clinical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Japanese Journal of Clinical Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Japanese Journal of Clinical Oncology?
The latest impact factor listed by LetPub is 2.48; CiteScore 3.7, h-index 116.
How long does peer review take at Japanese Journal of Clinical Oncology?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 38–91 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Japanese Journal of Clinical Oncology?
According to LetPub and DOAJ records, Japanese Journal of Clinical Oncology is indexed in SCIE and Scopus.
Is Japanese Journal of Clinical Oncology open access, and what is the APC?
Japanese Journal of Clinical Oncology is a hybrid journal. For open-access publication: APC about USD 3,604.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .